Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
第一作者:
H,Su
第一单位:
Laboratory of Intracellular Parasites, NIAID, Rocky Mountain Laboratories, Hamilton, MT 59840, USA.
作者:
主题词
投药, 阴道内(Administration, Intravaginal);动物(Animals);抗体, 细菌(Antibodies, Bacterial);细菌外膜蛋白质类(Bacterial Outer Membrane Proteins);细菌菌苗(Bacterial Vaccines);衣原体感染(Chlamydia Infections);沙眼衣原体(Chlamydia trachomatis);女(雌)性(Female);免疫球蛋白G(Immunoglobulin G);免疫球蛋白同型(Immunoglobulin Isotypes);注射, 皮下(Injections, Subcutaneous);小鼠(Mice);小鼠, 近交A(Mice, Inbred A);中和试验(Neutralization Tests);寡肽类(Oligopeptides);孔蛋白质类(Porins);子宫(Uterus);疫苗, 合成(Vaccines, Synthetic);阴道(Vagina);阴道疾病(Vaginal Diseases)
DOI
10.1016/0264-410x(95)00017-u
PMID
8525685
发布时间
2019-07-28
- 浏览18

Vaccine
1023-32页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文